2025中国医药核心渠道全景报告.docxVIP

2025中国医药核心渠道全景报告

1

集采常态化推进的背景下，2025年医院渠道及零售药店市场增长持续承压；DTP渠道凭借其创新药主阵地的定位，依然保持了稳健的增长韧性

中国医药市场全渠道表现(2020-2025)关键发现与洞察

单位：百万RMB

30%

21%12%0%1,551,53617%-2%

21%

12%

0%

1,551,536

17%

-2%

18%

11%

-3%

1,422,873

17%

12%

-2%-1%9%

-2%

-1%

-3%1,534,251104,901

-3%

1,534,251

104,901

374,820

-10%

1,532,754122,526364,301

1,532,754

122,526

364,301

89,785

385,826

74,493387,2291,265,63463,

74,493

387,229

1,265,634

54,

54,129

320,539

1,054,5301,075,9251,045,927961,151

1,054,530

1,075,925

1,045,927

961,151

890,966

20202021